Get started
Author

Robert C. Buttery

Observed names: R Buttery, R. Buttery, R. C. Buttery, R.C. Buttery, Robert Buttery
Observed institutions: National Health Service, University Hospitals Birmingham NHS Foundation Trust, University of Dundee, University of Cambridge, Royal Papworth Hospital, Hinchingbrooke Hospital, Public Health England, National Institute for Health and Care Research, University of Oxford, Papworth Hospital NHS Foundation Trust, Public Health Scotland, National Records of Scotland, Nepal Health Research Council, Oxford University Clinical Research Unit, Centre for Inflammation Research, Intensive Care National Audit & Research Centre, Hinchingbrooke Health Care NHS Trust, The Queen's Medical Research Institute, Oxford University Clinical Research Unit Indonesia, Medical Research Council, University of Edinburgh
OpenAlex ID: A5041904096
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Integrin activation by Fam38A uses a novel mechanism of R-Ras targeting to the endoplasmic reticulum
2009 · Brian J. McHugh, Robert Buttery, et al. · Journal of Cell Science · 216
EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy
2008 · Kurt G. Tournoy, Robert C. Rintoul, et al. · Lung Cancer · 161
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Gonadal Responses of the Male Syrian Hamster to Programmed Infusions of Melatonin are Sensitive to Signal Duration and Frequency but Not to Signal Phase Nor to Lesions of The Suprachiasmatic Nuclei1
1990 · E. S. Maywood, R. C. Buttery, et al. · Biology of Reproduction · 120
EBUS-TBNA for the Clarification of PET Positive Intra-Thoracic Lymph Nodes—an International Multi-Centre Experience
2009 · Robert C. Rintoul, Kurt G. Tournoy, et al. · Journal of Thoracic Oncology · 107
Cross-Linking CD98 Promotes Integrin-like Signaling and Anchorage-independent Growth
2002 · Robert C. Rintoul, Robert C. Buttery, et al. · Molecular Biology of the Cell · 91
Small cell lung cancer: the importance of the extracellular matrix
2004 · Robert C. Buttery, Robert C. Rintoul, et al. · The International Journal of Biochemistry & Cell Biology · 55
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Resectable Clinical N2 Non–Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group
2017 · Matthew Evison, Amelia Clive, et al. · Journal of Thoracic Oncology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Galectin‐3: differential expression between small‐cell and non‐small‐cell lung cancer
2004 · R Buttery, H Monaghan, et al. · Histopathology · 39
Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a β1-integrin pathway
2004 · Philip N. Newsome, John Tsiaoussis, et al. · Hepatology · 27
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2020 · Peter W Horby, Alistair Roddick, et al. · medRxiv · 17
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Haemophilus parainfluenzae endocarditis presenting with symptoms of COVID-19
2021 · Laurie C Finch, Spiro Gerdzhikov, et al. · BMJ Case Reports · 6
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
P105 Direct access pulmonary function testing for primary care
2011 · K. E. Backler, L. Leech, et al. · Thorax · 1
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
121 Bronchopulmonary carcinoid tumours: a retrospective analysis of 60 patients
2012 · M. King, D. Rassl, et al. · Lung Cancer
82 Establishing a virtual chemotherapy clinic from a regional cardiothoracic centre
2012 · D. Gilligan, S. Helme, et al. · Lung Cancer
Works count: 31
Citation count: 3,115
H-index: 17
I10-index: 19
Year
Topic
Type